In an effort to identify factors that may mediate the association between NAFLD and LGA, we tested FFA and adiponectin, both of which are potential biomarkers for fetal growth.[21, 25, 26] In the literature, the role of FFA in fetal growth is controversial, as FFA levels appear to be related to neonatal weight in patients with well controlled GDM, but not in nondiabetic pregnancies. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.